Advances in the treatment of metastatic melanoma have improved responses and survival.
However, many patients continue to experience resistance or toxicity to treatment …

The rate of advances in uveal melanoma has not kept pace with the rate of advances in
cutaneous melanoma. Many patients lack access to or knowledge of specialty centers, and …

Nonmelanoma skin cancers (NMSCs) are some of the most commonly diagnosed
malignancies. In general, early-stage NMSCs have favorable outcomes; however, a small …

Background Basal cell carcinoma (BCC) is the most common malignancy worldwide, yet the
management of patients with advanced or metastatic disease is challenging, with limited …

Purpose Stem cell transplant (SCT) recipients commonly undergo bronchoalveolar lavage
(BAL) collection as an infectious pulmonary work‐up. Previous studies report the utility and …

Background: The recent addition of immunotherapy as a treatment modality to surgery and
radiation has vastly improved disease control for patients with keratinocyte-derived …

A54-year-old man with a history of benign prostatic hypertrophy, hypothyroidism, and well-
controlled insulin-dependent diabetes mellitus secondary to idiopathic pancreatitis …

Immune therapies are showing remarkable improvements in disease outcomes for both
hematologic and oncologic malignancies, the history and progress of which are deeply …

Introduction: Myelofibrosis (MF) is a myeloid malignancy that may arise de novo as primary
MF or antecedent to essential thrombocythemia or polycythemia vera. Recent discoveries in …